- Fee assured
- Awaiting verification
- Soft tissue
Mark Verrill studied Medicine at the University of Cambridge and University College London, qualifying in 1989. He was awarded Membership of the Royal College of Physicians in 1993 and Fellowship in 2003. He undertook oncology Training at the Royal Marsden Hospital and institute of Cancer Research, London. He was appointed Cancer Research UK Senior Lecturer in Medical Oncology at Newcastle University and Honorary Consultant Medical Oncologist in the Newcastle Hospitals Trust in 1999. He moved in to his current NHS post in 2007.
He is internationally respected for his clinical trials work in breast cancer and regarded as a "key opinion leader". He has lectured on breast cancer all over the world.
Areas of interest
Breast Cancer; Gastro-intestinal stroll tumours; Soft Tissue Sarcoma
Current NHS consultant posts held
Consultant Medical Oncologist & Head of the Department of Medical Oncology, Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne
Systemic Anticancer Therapies for Breast Cancer. Breast Cancer. Previously Member of the National Cancer Research Institute (NCRI) Breast Cancer Studies Group (CSG), UK Breast Breast Intergroup and Anglo-Celtic Co-operative Oncology Group.
Soft Tissue and Bone Sarcomas, Gastrointestinal Stromal Tumours. Former member of the NCRI Sarcoma CSG. Member of the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Lancet, Journal of Clinical Oncology, British Journal of Cancer, Annals of Oncology, Clinical Cancer Research
- BA University of Cambridge 1986
- MA University of Cambridge 1987
- MB BChir University of Cambridge 1989
- MRCP Royal College of Physicians (London) 1993
- FRCP Royal College of Physicians (London) 2003
Reference number 3320972
Affiliations / memberships
British Association for Cancer Research
Association of Cancer Physicians
American Society of Clinical Oncology
- Royal Victoria Infirmary, NE1 4LP
- 18:00 - 20:30
- 07725 530694
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.